Proposal To Improve Patient Information Attracts More EU Support
This article was originally published in The Pink Sheet Daily
Pharma is relieved as an EU parliamentary committee approves revised information-to-patients proposals
You may also be interested in...
The head of EFPIA believes drug makers are squandering opportunities offered by mobile health applications, a key point in the European trade body’s new manifesto.
Global health systems are losing billions of dollars by not introducing schemes to tackle drug adherence, but are heading in the right direction with patient-centric drug development.
European Commission's surprise update of the pharmacovigilance rules is included in its review of the information to patients legislation, but industry's biggest concern may be the failure to address the role of social media.